RE:RE:36x-70x upside based on similar BTD for BCG-unresponsiveVery true ScienceFirst we could be and will be valued much higher than a multiple of current share price. An awarded BTD would value the share price on speculated earnings for NMIBC in its first year of commercialization, something I've drawn up in a possible evaluation in the past. Although all my projections were only taken on capturing 10% of the market in Theralase's first year there is also the possibility they can grab a larger slice. Wonder how close or how far once it happens will my numbers be.